Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations
US12310970B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2023 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Jul 7, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of treating retinal degenerations, such as but not limited to anterior segment ocular disorders and/or age-related macular degeneration (AMD), in a subject, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of a compound of formula (1) or formula (2). In a further aspect, the invention provides compounds of formula (2). In certain embodiments, the compounds of the invention prevent or minimize cellular assault, such as oxidative stress-related cellular assault, and/or promote cell viability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.